The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma

The microbiome is pivotal in maintaining health and influencing disease by modulating essential inflammatory and immune responses. Hepatocellular carcinoma (HCC), ranking as the third most common cause of cancer-related fatalities globally, is influenced by the gut microbiome through bidirectional i...

Full description

Bibliographic Details
Main Authors: Betul Gok Yavuz, Saumil Datar, Shadi Chamseddine, Yehia I. Mohamed, Michael LaPelusa, Sunyoung S. Lee, Zishuo Ian Hu, Eugene J. Koay, Hop S. Tran Cao, Prasun Kumar Jalal, Carrie Daniel-MacDougall, Manal Hassan, Dan G. Duda, Hesham M. Amin, Ahmed O. Kaseb
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
hepatocellular carcinoma
gut microbiome
therapeutic target
biomarkers
Online Access:https://www.mdpi.com/2072-6694/15/19/4875

Internet

https://www.mdpi.com/2072-6694/15/19/4875

Similar Items